Protalix BioTherapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Protalix BioTherapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -16.6 %, a 225% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Return On Assets for 2023 was 10.2 %.
  • Protalix BioTherapeutics, Inc. annual Return On Assets for 2022 was -24.7 %, a 17.5% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Return On Assets for 2021 was -30 %, a 239% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -16.6 -29.9 -225% Apr 1, 2024 Jun 30, 2024
Q1 2024 7.82 +34.1 Jan 1, 2024 Mar 31, 2024
Q4 2023 10.2 +34.9 Oct 1, 2023 Dec 31, 2023
Q3 2023 14.2 +41.8 Jul 1, 2023 Sep 30, 2023
Q2 2023 13.3 +39.2 Apr 1, 2023 Jun 30, 2023
Q1 2023 -26.3 +2.92 +9.99% Jan 1, 2023 Mar 31, 2023
Q4 2022 -24.7 +5.25 +17.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -27.5 -4.88 -21.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.8 -2.2 -9.31% Apr 1, 2022 Jun 30, 2022
Q1 2022 -29.2 -11.9 -68.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -30 -21.1 -239% Oct 1, 2021 Dec 31, 2021
Q3 2021 -22.7 -12.9 -133% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.6 -14.6 -161% Apr 1, 2021 Jun 30, 2021
Q1 2021 -17.4 -1.61 -10.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -8.85 +25.1 +73.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -9.74 +31.8 +76.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -9.07 +33.3 +78.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -15.8 +28.5 +64.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -33.9 +9.54 +21.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -41.5 +12.4 +23% Jul 1, 2019 Sep 30, 2019
Q2 2019 -42.4 +22.4 +34.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -44.2 +4.86 +9.91% Jan 1, 2019 Mar 31, 2019
Q4 2018 -43.5 +82.9 +65.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -54 +52.2 +49.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -64.8 +32 +33.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -49.1 +56.3 +53.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -126 -89.5 -243% Oct 1, 2017 Dec 31, 2017
Q3 2017 -106 -161 -292% Jul 1, 2017 Sep 30, 2017
Q2 2017 -96.8 -158 -257% Apr 1, 2017 Jun 30, 2017
Q1 2017 -105 -177 -247% Jan 1, 2017 Mar 31, 2017
Q4 2016 -36.8 -116 -147% Oct 1, 2016 Dec 31, 2016
Q3 2016 55.3 +89.1 Jul 1, 2016 Sep 30, 2016
Q2 2016 61.5 +98 Apr 1, 2016 Jun 30, 2016
Q1 2016 71.5 +106 Jan 1, 2016 Mar 31, 2016
Q4 2015 78.8 +112 Oct 1, 2015 Dec 31, 2015
Q3 2015 -33.8 -1.33 -4.09% Jul 1, 2015 Sep 30, 2015
Q2 2015 -36.6 -8.85 -31.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 -34.4 -3.64 -11.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -33 -2.66 -8.78% Oct 1, 2014 Dec 31, 2014
Q3 2014 -32.5 -0.25 -0.78% Jul 1, 2014 Sep 30, 2014
Q2 2014 -27.7 +9.08 +24.7% Apr 1, 2014 Jun 30, 2014
Q1 2014 -30.8 -17.9 -138% Jan 1, 2014 Mar 31, 2014
Q4 2013 -30.3 -15.3 -101% Oct 1, 2013 Dec 31, 2013
Q3 2013 -32.3 -17.1 -113% Jul 1, 2013 Sep 30, 2013
Q2 2013 -36.8 -15.6 -73.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -12.9 +46.2 +78.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -15.1 Oct 1, 2012 Dec 31, 2012
Q3 2012 -15.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -21.2 Apr 1, 2012 Jun 30, 2012
Q1 2012 -59.1 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.